No... it is the new Aspercreme Lidocaine that this thread is about.
The Emla in the study is very similar:
Quote:
|
Lidocaine/prilocaine is a eutectic mixture of equal quantities (by weight) of lidocaine and prilocaine. A 5% emulsion preparation, containing 2.5% each of lidocaine/prilocaine, is marketed by APP Pharmaceuticals under the trade name EMLA (an abbreviation for Eutectic Mixture of Local Anesthetics).[1]
|
from
https://en.wikipedia.org/wiki/Lidocaine/prilocaine
The Aspercreme is only lidocaine at 4% strength.
Emla was originally RX and used prior to biopsies, wart removal, or other dermatological lesions. It was commonly used for children having blood draws. Typically it was applied, covered with saran wrap for about 30 minutes, to force it deeply into the skin, before the tests.
Our FDA had resisted allowing lidocaine OTC ever. But times have changed, I see, and now it seems allowed OTC in strengths below 5%. This study was done with EMLA because the Aspercreme version was not available then....and also because doctors are familiar with EMLA.
__________________
All truths are easy to understand once they are discovered; the point is to discover them.-- Galileo Galilei
************************************
.
Weezie looking at petunias 8.25.2017
****************************
These forums are for mutual support and information sharing only. The forums are not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Always consult your doctor before trying anything you read here.